Encapsulated Rose Bengal Enhances the Photodynamic Treatment of Triple-Negative Breast Cancer Cells

Among breast cancer subtypes, triple-negative breast cancer stands out as the most aggressive, with patients facing a 40% mortality rate within the initial five years. The limited treatment options and unfavourable prognosis for triple-negative patients necessitate the development of novel therapeut...

Full description

Bibliographic Details
Main Authors: Mir Muhammad Nasir Uddin, Alina Bekmukhametova, Anu Antony, Shital K. Barman, Jessica Houang, Ming J. Wu, James M. Hook, Laurel George, Richard Wuhrer, Damia Mawad, Daniel Ta, Herleen Ruprai, Antonio Lauto
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/29/2/546
_version_ 1797339472849797120
author Mir Muhammad Nasir Uddin
Alina Bekmukhametova
Anu Antony
Shital K. Barman
Jessica Houang
Ming J. Wu
James M. Hook
Laurel George
Richard Wuhrer
Damia Mawad
Daniel Ta
Herleen Ruprai
Antonio Lauto
author_facet Mir Muhammad Nasir Uddin
Alina Bekmukhametova
Anu Antony
Shital K. Barman
Jessica Houang
Ming J. Wu
James M. Hook
Laurel George
Richard Wuhrer
Damia Mawad
Daniel Ta
Herleen Ruprai
Antonio Lauto
author_sort Mir Muhammad Nasir Uddin
collection DOAJ
description Among breast cancer subtypes, triple-negative breast cancer stands out as the most aggressive, with patients facing a 40% mortality rate within the initial five years. The limited treatment options and unfavourable prognosis for triple-negative patients necessitate the development of novel therapeutic strategies. Photodynamic therapy (PDT) is an alternative treatment that can effectively target triple-negative neoplastic cells such as MDA-MB-231. In this in vitro study, we conducted a comparative analysis of the PDT killing rate of unbound Rose Bengal (RB) in solution versus RB-encapsulated chitosan nanoparticles to determine the most effective approach for inducing cytotoxicity at low laser powers (90 mW, 50 mW, 25 mW and 10 mW) and RB concentrations (50 µg/mL, 25 µg/mL, 10 µg/mL and 5 µg/mL). Intracellular singlet oxygen production and cell uptake were also determined for both treatment modalities. Dark toxicity was also assessed for normal breast cells. Despite the low laser power and concentration of nanoparticles (10 mW and 5 µg/mL), MDA-MB-231 cells experienced a substantial reduction in viability (8 ± 1%) compared to those treated with RB solution (38 ± 10%). RB nanoparticles demonstrated higher singlet oxygen production and greater uptake by cancer cells than RB solutions. Moreover, RB nanoparticles display strong cytocompatibility with normal breast cells (MCF-10A). The low activation threshold may be a crucial advantage for specifically targeting malignant cells in deep tissues.
first_indexed 2024-03-08T09:48:38Z
format Article
id doaj.art-4c0693d494584cc09b29db2047a34e69
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-03-08T09:48:38Z
publishDate 2024-01-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-4c0693d494584cc09b29db2047a34e692024-01-29T14:09:28ZengMDPI AGMolecules1420-30492024-01-0129254610.3390/molecules29020546Encapsulated Rose Bengal Enhances the Photodynamic Treatment of Triple-Negative Breast Cancer CellsMir Muhammad Nasir Uddin0Alina Bekmukhametova1Anu Antony2Shital K. Barman3Jessica Houang4Ming J. Wu5James M. Hook6Laurel George7Richard Wuhrer8Damia Mawad9Daniel Ta10Herleen Ruprai11Antonio Lauto12School of Science, Western Sydney University, Penrith, NSW 2750, AustraliaSchool of Science, Western Sydney University, Penrith, NSW 2750, AustraliaSchool of Science, Western Sydney University, Penrith, NSW 2750, AustraliaSchool of Science, Western Sydney University, Penrith, NSW 2750, AustraliaSchool of Science, Western Sydney University, Penrith, NSW 2750, AustraliaSchool of Science, Western Sydney University, Penrith, NSW 2750, AustraliaSchool of Chemistry, University of New South Wales, Sydney, NSW 2052, AustraliaAdvanced Materials Characterisation Facility, Western Sydney University, Penrith, NSW 2750, AustraliaAdvanced Materials Characterisation Facility, Western Sydney University, Penrith, NSW 2750, AustraliaSchool of Materials Science and Engineering and Australian Centre for NanoMedicine, University of New South Wales, Kensington, NSW 2052, AustraliaSchool of Science, Western Sydney University, Penrith, NSW 2750, AustraliaSchool of Science, Western Sydney University, Penrith, NSW 2750, AustraliaSchool of Science, Western Sydney University, Penrith, NSW 2750, AustraliaAmong breast cancer subtypes, triple-negative breast cancer stands out as the most aggressive, with patients facing a 40% mortality rate within the initial five years. The limited treatment options and unfavourable prognosis for triple-negative patients necessitate the development of novel therapeutic strategies. Photodynamic therapy (PDT) is an alternative treatment that can effectively target triple-negative neoplastic cells such as MDA-MB-231. In this in vitro study, we conducted a comparative analysis of the PDT killing rate of unbound Rose Bengal (RB) in solution versus RB-encapsulated chitosan nanoparticles to determine the most effective approach for inducing cytotoxicity at low laser powers (90 mW, 50 mW, 25 mW and 10 mW) and RB concentrations (50 µg/mL, 25 µg/mL, 10 µg/mL and 5 µg/mL). Intracellular singlet oxygen production and cell uptake were also determined for both treatment modalities. Dark toxicity was also assessed for normal breast cells. Despite the low laser power and concentration of nanoparticles (10 mW and 5 µg/mL), MDA-MB-231 cells experienced a substantial reduction in viability (8 ± 1%) compared to those treated with RB solution (38 ± 10%). RB nanoparticles demonstrated higher singlet oxygen production and greater uptake by cancer cells than RB solutions. Moreover, RB nanoparticles display strong cytocompatibility with normal breast cells (MCF-10A). The low activation threshold may be a crucial advantage for specifically targeting malignant cells in deep tissues.https://www.mdpi.com/1420-3049/29/2/546triple-negative breast cancerlaserstumoursRose Bengalreactive oxygen species
spellingShingle Mir Muhammad Nasir Uddin
Alina Bekmukhametova
Anu Antony
Shital K. Barman
Jessica Houang
Ming J. Wu
James M. Hook
Laurel George
Richard Wuhrer
Damia Mawad
Daniel Ta
Herleen Ruprai
Antonio Lauto
Encapsulated Rose Bengal Enhances the Photodynamic Treatment of Triple-Negative Breast Cancer Cells
Molecules
triple-negative breast cancer
lasers
tumours
Rose Bengal
reactive oxygen species
title Encapsulated Rose Bengal Enhances the Photodynamic Treatment of Triple-Negative Breast Cancer Cells
title_full Encapsulated Rose Bengal Enhances the Photodynamic Treatment of Triple-Negative Breast Cancer Cells
title_fullStr Encapsulated Rose Bengal Enhances the Photodynamic Treatment of Triple-Negative Breast Cancer Cells
title_full_unstemmed Encapsulated Rose Bengal Enhances the Photodynamic Treatment of Triple-Negative Breast Cancer Cells
title_short Encapsulated Rose Bengal Enhances the Photodynamic Treatment of Triple-Negative Breast Cancer Cells
title_sort encapsulated rose bengal enhances the photodynamic treatment of triple negative breast cancer cells
topic triple-negative breast cancer
lasers
tumours
Rose Bengal
reactive oxygen species
url https://www.mdpi.com/1420-3049/29/2/546
work_keys_str_mv AT mirmuhammadnasiruddin encapsulatedrosebengalenhancesthephotodynamictreatmentoftriplenegativebreastcancercells
AT alinabekmukhametova encapsulatedrosebengalenhancesthephotodynamictreatmentoftriplenegativebreastcancercells
AT anuantony encapsulatedrosebengalenhancesthephotodynamictreatmentoftriplenegativebreastcancercells
AT shitalkbarman encapsulatedrosebengalenhancesthephotodynamictreatmentoftriplenegativebreastcancercells
AT jessicahouang encapsulatedrosebengalenhancesthephotodynamictreatmentoftriplenegativebreastcancercells
AT mingjwu encapsulatedrosebengalenhancesthephotodynamictreatmentoftriplenegativebreastcancercells
AT jamesmhook encapsulatedrosebengalenhancesthephotodynamictreatmentoftriplenegativebreastcancercells
AT laurelgeorge encapsulatedrosebengalenhancesthephotodynamictreatmentoftriplenegativebreastcancercells
AT richardwuhrer encapsulatedrosebengalenhancesthephotodynamictreatmentoftriplenegativebreastcancercells
AT damiamawad encapsulatedrosebengalenhancesthephotodynamictreatmentoftriplenegativebreastcancercells
AT danielta encapsulatedrosebengalenhancesthephotodynamictreatmentoftriplenegativebreastcancercells
AT herleenruprai encapsulatedrosebengalenhancesthephotodynamictreatmentoftriplenegativebreastcancercells
AT antoniolauto encapsulatedrosebengalenhancesthephotodynamictreatmentoftriplenegativebreastcancercells